GetTopicDetailResponse(id=344d4490531, topicName=妊娠滋養(yǎng)細胞腫瘤, introduction=妊娠滋養(yǎng)細胞腫瘤, content=null, image=null, comments=4, allHits=1405, url=https://h5.medsci.cn/topic?id=44905, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=74158, tagList=[TagDto(tagId=74158, tagName=妊娠滋養(yǎng)細胞腫瘤)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2105177, encodeId=264f21051e7d5, content=<a href='/topic/show?id=344d4490531' target=_blank style='color:#2F92EE;'>#妊娠滋養(yǎng)細胞腫瘤#</a>化療后<a href='/topic/show?id=da531050e508' target=_blank style='color:#2F92EE;'>#意外妊娠#</a>，這是好問題，臨床上很難選擇, objectTitle=妊娠滋養(yǎng)細胞腫瘤化療后意外妊娠——如何抉擇？, objectType=article, longId=751339, objectId=2877e51339dd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221121/1669073014035_4754896.webp, objectUrl=/article/show_article.do?id=2877e51339dd, replyNumber=0, likeNumber=120, createdTime=2022-12-10, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2877e51339dd, moduleTitle=妊娠滋養(yǎng)細胞腫瘤化療后意外妊娠——如何抉擇？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2877e51339dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634471, encodeId=95a916344e190, content=<a href='/topic/show?id=344d4490531' target=_blank style='color:#2F92EE;'>#妊娠滋養(yǎng)細胞腫瘤#</a>, objectTitle=Lancet Oncol：卡瑞珠單抗聯(lián)合阿帕替尼有望成為化療難治性/復發(fā)性妊娠滋養(yǎng)細胞腫瘤的挽救治療方案！, objectType=article, longId=218250, objectId=f5da2182509d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5da2182509d, replyNumber=0, likeNumber=102, createdTime=2021-11-13, rootId=0, userName=wenzhiren, userId=33c522182803, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5da2182509d, moduleTitle=Lancet Oncol：卡瑞珠單抗聯(lián)合阿帕替尼有望成為化療難治性/復發(fā)性妊娠滋養(yǎng)細胞腫瘤的挽救治療方案！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f5da2182509d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634470, encodeId=cd4916344e069, content=<a href='/topic/show?id=344d4490531' target=_blank style='color:#2F92EE;'>#妊娠滋養(yǎng)細胞腫瘤#</a>, objectTitle=ARCH PATHOL LAB MED：妊娠滋養(yǎng)細胞腫瘤, objectType=article, longId=159484, objectId=9fd81594845d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fd81594845d, replyNumber=0, likeNumber=86, createdTime=2019-11-12, rootId=0, userName=wenzhiren, userId=33c522182803, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fd81594845d, moduleTitle=ARCH PATHOL LAB MED：妊娠滋養(yǎng)細胞腫瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9fd81594845d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634469, encodeId=d868163446998, content=<a href='/topic/show?id=344d4490531' target=_blank style='color:#2F92EE;'>#妊娠滋養(yǎng)細胞腫瘤#</a>, objectTitle=郭瑞霞教授：妊娠滋養(yǎng)細胞腫瘤，可被化療攻克的癌癥, objectType=article, longId=136838, objectId=515c136838ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=515c136838ac, replyNumber=0, likeNumber=92, createdTime=2018-10-08, rootId=0, userName=wenzhiren, userId=33c522182803, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=515c136838ac, moduleTitle=郭瑞霞教授：妊娠滋養(yǎng)細胞腫瘤，可被化療攻克的癌癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=515c136838ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
